Loading…
Saved in:
Source: | npj Precision Oncology, Vol 8, Iss 1, Pp 1-9 (2024) |
---|---|
Publisher Information: | Nature Portfolio, 2024. |
Publication Year: | 2024 |
Subject Terms: | Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
Description: |
Abstract Aberrant activation of tropomyosin receptor kinases (TRKs) is a well-defined oncogenic driver for neurotrophic tropomyosin receptor
|
Database: | Directory of Open Access Journals |